How much is the omvoh market worth, and how is it expected to expand?
The omvoh market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growing autoimmune disorders, increasing clinical trials, growing healthcare infrastructure, increasing government initiatives, and a growing geriatric population.
The omvoh market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing investments in research and development activities, rising disposable income, growing drug approvals, growing cancer disorders, and growing awareness of autoimmune disorders. Major trends in the forecast period include drug approval by authorities, technological advancement in combination therapy, growing demand for personalized medicine, growing research and development activities, and facility expansion.
Get Your Free Sample of The Global Omvoh Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20323&type=smp
Which industry factors have accelerated the omvoh market’s expansion?
The rising autoimmune disease is expected to drive the growth of the omvoh market going forward. Autoimmune diseases are a group of conditions in which the immune system, which usually defends the body against infections and other harmful invaders, mistakenly attacks the body’s healthy cells, tissues, or organs. The rise in autoimmune diseases can be attributed to several factors, including genetic predisposition, lifestyle factors, hormonal changes, and an aging population. Omvoh helps by restoring immune balance, neutralizing harmful antibodies, providing passive immunity, alleviating symptoms, reducing inflammation, and preventing further tissue damage in autoimmune diseases. For instance, in July 2024, according to the National Health Service (NHS) England, a UK-based government department, multiple sclerosis affects over 150,000 people in the UK, with more than 120,000 in England, and is more prevalent in women. Approximately 135 new diagnoses are made each week, highlighting its significant impact on the population. Therefore, the rise of autoimmune diseases will drive the growth of the omvoh market.
What are the primary segments of the omvoh market?
The omvoh market covered in this report is segmented –
1) By Formulation: Tablets Or Capsules; Injectables
2) By Clinical Indication: Ulcerative Colitis (UC); Crohn’s Disease; Psoriasis; Other Inflammatory Diseases
3) By End-User: Hospitals And Clinics; Pharmacies; Research Institutions
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/omvoh-global-market-report
Which firms are leading the omvoh market?
Major companies operating in the omvoh market are Eli Lilly and Company
Which market trends are set to define the future of the omvoh market?
The key trend in the omvoh market is developing advanced interleukin-23p19 (IL-23p19) antagonists to enhance the treatment of autoimmune diseases and improve patient outcomes. An interleukin-23p19 (IL-23p19) antagonist is a therapeutic agent that targets and blocks the p19 subunit of IL-23, a cytokine involved in inflammation. By inhibiting IL-23, these antagonists help control the immune response, reduce inflammation, and slow the progression of autoimmune diseases. For instance, in December 2024, Eli Lilly and Company, a US-based pharmaceutical company, announced that Omvoh has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for approval in the European Union for the treatment of adults with moderately to severely active Crohn’s disease. This recommendation is supported by data from the Phase 3 VIVID-1 trial, which demonstrated significant improvements in clinical and endoscopic outcomes compared to placebo and an active control.
Which geographic trends are shaping the omvoh market, and which region has the highest market share?
North America was the largest region in the omvoh market in 2024. The regions covered in the omvoh market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Omvoh Market Report 2025 Offer?
The omvoh market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Omvoh is a prescription medication containing the active ingredient mirikizumab-mrkz, a monoclonal antibody that targets the p19 subunit of interleukin-23 (IL-23), a protein involved in inflammatory processes. It is indicated for treating adults with moderately to severely active ulcerative colitis. The treatment regimen typically begins with intravenous (IV) infusions during the induction phase, followed by subcutaneous injections for maintenance.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20323
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
